Tunisian Lung Cancer Study
ConditionPulmonary Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDacima Consulting
About this trial
This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.
Eligibility criteria
Qualifiers
Age more than 18 years
Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
Informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Dacima Consulting
Lead sponsor
The Multidisciplinary Consultation Meeting Thoracic Oncology of the Abderrahmen Mami Hospital (ROTHAM)
Collaborator
Tunisian Society of Respiratory Diseases and Allergology
Collaborator
Tunisian Society of Medical Oncology
Collaborator
Source ClinicalTrials.gov